2018-04-27 11:46
Biovica takes the next step in the process of commercializing DiviTum by launching a subsidiary in the United States.
2018-04-24 10:08
Uppsala, Sweden, 2018-04-23, In accordance with the decision of the Annual General Meeting of Biovica International AB on August 31st, 2017, the Nomination Committee shall consist of three members, representing the two shareholders with the highest number...
2018-04-17 08:30
Uppsala, Sweden, 2018-04-17, New results from a Pfizer study on Ibrance® (palbociclib, Pfizer) of women with metastatic breast cancer demonstrate that DiviTum can provide fast evaluation of biologic effect demonstrating CDK 4/6 inhibition.
2018-03-28 08:00
Uppsala, Sweden, 2018-03-28
Results from a study of women with metastatic breast cancer demonstrate that DiviTum can provide faster evaluation of treatment efficacy than today’s standard methods and give precise prognosis.
2018-03-20 08:00
Uppsala, Sweden 2018-03-20
Biovica has received an order for the company's DiviTum® product from a global diagnostic and contract research company (CRO company). DiviTum will be used during the development of a new targeted drug against cancer to...
2018-02-22 11:53
Johns Hopkins University, Maryland, USA includes DiviTum® in a new study of metastatic breast cancer to study the development of resistance and efficacy of the new drug Ibrance® (palbociclib, Pfizer).
2017-12-05 08:30
Uppsala, December 5, 2017. Biovica has appointed Adam Germunder as new Operations Manager. Adams responsibilities include to build and secure the company’s production capabilities and ensure that they meet regulatory requirements in preparation for...
2017-11-23 08:00
Uppsala, Sweden, November 23, 2017. Results of a study from Washington University, St Louis, demonstrate that the DiviTum® can evaluate the biologic activity of Pfizer’s breast cancer drug palbociclib (Ibrance®) in just two weeks are published in...
2017-11-21 08:00
Uppsala, Sweden, November 21, 2017. In collaboration with University of Heidelberg, Germany, results from a clinical study of pancreatic cancer is published in the Pancreas scientific journal. The results demonstrate that Biovica’s DiviTum assay can...
2017-11-14 08:00
Uppsala, Sweden, November 14, 2017. Results from a study of 142 women with newly diagnosed metastatic breast cancer will be presented by researchers from Lund University at the world’s biggest breast cancer conference in San Antonio, USA. The study...
>4,500
Numbers of patients in studies
28
Publications
32
Pharma Projects